Dr Khademhosseini is the CEO and Director of the Terasaki Institute in Los Angeles, one of the leaders in researching the use of nanotechnology for minimally invasive medical procedures. Formerly, Khademhosseini was the Levi Knight Professor of Bioengineering, Chemical Engineering, and Radiology at UCLA and a Professor at Harvard Medical School. He is the author of more than 650 peer-reviewed journal articles, editorials and review papers and holds more than 70 patents. He is the recipient of the Presidential Early Career Award for Scientists and Engineers (PECASE); and every year since 2014 Khademhosseini has been selected by Thomson Reuters as one of the World’s Most Influential Minds as a Highly Cited Researcher. He has been awarded many more honours, such as the Mustafa Prize, the Pioneers of Miniaturization Prize from the Royal Society of Chemistry (RSC) and the Clemson Award of the Society for Biomaterials.